MEF Menu
Middle East ForumSupport MEF
Middle East ForumGulf Sovereign Holdings

All Holdings

Mamoura Diversified Global Holding in Recursion Pharmaceuticals, Inc.

Completed. First disclosed April 15, 2021, in a Form 3 (source).

Investor
Mamoura Diversified Global Holding (United Arab Emirates)
Parent
Mubadala Investment Company
Target
Recursion Pharmaceuticals, Inc. (EDGAR CIK 1601830)
Target country
United States
Sector
Health and Life Sciences (SIC 2836)
First disclosed
April 15, 2021, Form 3
Amount
Not stated
Stake at first disclosure
Not stated

Source Filings and Releases

Oldest first
DateDocumentStated stakeLink
April 15, 2021Form 3Not applicableView
April 20, 2021Form 4Not applicableView
October 31, 2022Form 4Not applicableView
January 13, 2023Form 4Not applicableView
January 26, 2023Form 4Not applicableView
January 27, 2023Form 4Not applicableView
February 2, 2023Form 4Not applicableView
February 13, 2023Form 4Not applicableView
February 14, 2023Form 4Not applicableView
February 15, 2023Form 4Not applicableView
February 17, 2023Form 4Not applicableView
February 21, 2023Form 4Not applicableView
February 22, 2023Form 4Not applicableView
February 23, 2023Form 4Not applicableView
February 24, 2023Form 4Not applicableView
February 27, 2023Form 4Not applicableView
February 28, 2023Form 4Not applicableView
March 1, 2023Form 4Not applicableView
March 2, 2023Form 4Not applicableView
March 3, 2023Form 4Not applicableView

Cite: Middle East Forum, “Mamoura Diversified Global Holding in Recursion Pharmaceuticals, Inc.,” Gulf Sovereign Holdings, accessed October 13, 2026, https://statemoney.meforum.org/deal/mamoura-recursion-pharmaceuticals-inc-1601830/.

Gulf money also reaches U.S. universities and lobbyists: the Influence Tracker holds Section 117 gift and contract disclosures and FARA registrations, and the Campus Watch Map places that funding on specific campuses.